Impact of the COVID-19 breast cancer screening hiatus on clinical stage and racial disparities in New York City

Am J Surg. 2022 Oct;224(4):1039-1045. doi: 10.1016/j.amjsurg.2022.05.037. Epub 2022 May 27.

Abstract

Background: The impact of the COVID-19 mammography screening hiatus as well as of post-hiatus efforts promoting restoration of elective healthcare on breast cancer detection patterns and stage distribution is unknown.

Methods: Newly diagnosed breast cancer patients (2019-2021) at the New York Presbyterian (NYP) Hospital Network were analyzed. Chi-square and student's t-test compared characteristics of patients presenting before and after the screening hiatus.

Results: A total of 2137 patients were analyzed. Frequency of screen-detected and early-stage breast cancer declined post-hiatus (59.7%), but returned to baseline (69.3%). Frequency of screen-detected breast cancer was lowest for African American (AA) (57.5%) and Medicaid patients pre-hiatus (57.2%), and this disparity was reduced post-hiatus (65.3% for AA and 63.2% for Medicaid).

Conclusions: The return to baseline levels of screen-detected cancer, particularly among AA and Medicaid patients suggest that large-scale breast health education campaigns may be effective in resuming screening practices and in mitigating disparities.

Keywords: Breast cancer; COVID-19; Healthcare disparities; Mammography; Screening.

MeSH terms

  • Breast Neoplasms* / diagnosis
  • Breast Neoplasms* / prevention & control
  • COVID-19* / epidemiology
  • Early Detection of Cancer
  • Female
  • Healthcare Disparities
  • Humans
  • Mammography
  • Mass Screening
  • New York City / epidemiology
  • United States